242 related articles for article (PubMed ID: 16712895)
1. Different European-type vaccines against porcine reproductive and respiratory syndrome virus have different immunological properties and confer different protection to pigs.
Díaz I; Darwich L; Pappaterra G; Pujols J; Mateu E
Virology; 2006 Aug; 351(2):249-59. PubMed ID: 16712895
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of a modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in pigs naturally exposed to a heterologous European (Italian cluster) field strain: Clinical protection and cell-mediated immunity.
Martelli P; Gozio S; Ferrari L; Rosina S; De Angelis E; Quintavalla C; Bottarelli E; Borghetti P
Vaccine; 2009 Jun; 27(28):3788-99. PubMed ID: 19442420
[TBL] [Abstract][Full Text] [Related]
3. Assessment of the efficacy of commercial porcine reproductive and respiratory syndrome virus (PRRSV) vaccines based on measurement of serologic response, frequency of gamma-IFN-producing cells and virological parameters of protection upon challenge.
Zuckermann FA; Garcia EA; Luque ID; Christopher-Hennings J; Doster A; Brito M; Osorio F
Vet Microbiol; 2007 Jul; 123(1-3):69-85. PubMed ID: 17376612
[TBL] [Abstract][Full Text] [Related]
4. Immune responses of pigs inoculated with a recombinant fowlpox virus coexpressing GP5/GP3 of porcine reproductive and respiratory syndrome virus and swine IL-18.
Shen G; Jin N; Ma M; Jin K; Zheng M; Zhuang T; Lu H; Zhu G; Jin H; Jin M; Huo X; Qin X; Yin R; Li C; Li H; Li Y; Han Z; Chen Y; Jin M
Vaccine; 2007 May; 25(21):4193-202. PubMed ID: 17418456
[TBL] [Abstract][Full Text] [Related]
5. Immune responses and protection by vaccine and various vaccine adjuvant candidates to virulent porcine reproductive and respiratory syndrome virus.
Charerntantanakul W; Platt R; Johnson W; Roof M; Vaughn E; Roth JA
Vet Immunol Immunopathol; 2006 Jan; 109(1-2):99-115. PubMed ID: 16165219
[TBL] [Abstract][Full Text] [Related]
6. Similarity of European porcine reproductive and respiratory syndrome virus strains to vaccine strain is not necessarily predictive of the degree of protective immunity conferred.
Prieto C; Alvarez E; Martínez-Lobo FJ; Simarro I; Castro JM
Vet J; 2008 Mar; 175(3):356-63. PubMed ID: 17560818
[TBL] [Abstract][Full Text] [Related]
7. Protection and immune response in pigs intradermally vaccinated against porcine reproductive and respiratory syndrome (PRRS) and subsequently exposed to a heterologous European (Italian cluster) field strain.
Martelli P; Cordioli P; Alborali LG; Gozio S; De Angelis E; Ferrari L; Lombardi G; Borghetti P
Vaccine; 2007 Apr; 25(17):3400-8. PubMed ID: 17276558
[TBL] [Abstract][Full Text] [Related]
8. Lymphocyte activation as cytokine gene expression and secretion is related to the porcine reproductive and respiratory syndrome virus (PRRSV) isolate after in vitro homologous and heterologous recall of peripheral blood mononuclear cells (PBMC) from pigs vaccinated and exposed to natural infection.
Ferrari L; Martelli P; Saleri R; De Angelis E; Cavalli V; Bresaola M; Benetti M; Borghetti P
Vet Immunol Immunopathol; 2013 Feb; 151(3-4):193-206. PubMed ID: 23228653
[TBL] [Abstract][Full Text] [Related]
9. Immunologic responses and reproductive outcomes following exposure to wild-type or attenuated porcine reproductive and respiratory syndrome virus in swine under field conditions.
Lowe JF; Zuckermann FA; Firkins LD; Schnitzlein WM; Goldberg TL
J Am Vet Med Assoc; 2006 Apr; 228(7):1082-8. PubMed ID: 16579789
[TBL] [Abstract][Full Text] [Related]
10. HSP70 fused with GP3 and GP5 of porcine reproductive and respiratory syndrome virus enhanced the immune responses and protective efficacy against virulent PRRSV challenge in pigs.
Li J; Jiang P; Li Y; Wang X; Cao J; Wang X; Zeshan B
Vaccine; 2009 Feb; 27(6):825-32. PubMed ID: 19070639
[TBL] [Abstract][Full Text] [Related]
11. Impact of genetic diversity of European-type porcine reproductive and respiratory syndrome virus strains on vaccine efficacy.
Labarque G; Reeth KV; Nauwynck H; Drexler C; Van Gucht S; Pensaert M
Vaccine; 2004 Oct; 22(31-32):4183-90. PubMed ID: 15474708
[TBL] [Abstract][Full Text] [Related]
12. Positive inductive effect of IL-2 on virus-specific cellular responses elicited by a PRRSV-ORF7 DNA vaccine in swine.
Rompato G; Ling E; Chen Z; Van Kruiningen H; Garmendia AE
Vet Immunol Immunopathol; 2006 Jan; 109(1-2):151-60. PubMed ID: 16162362
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Two Commercial Type 1 Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) Modified Live Vaccines against Heterologous Type 1 and Type 2 PRRSV Challenge in Growing Pigs.
Kim T; Park C; Choi K; Jeong J; Kang I; Park SJ; Chae C
Clin Vaccine Immunol; 2015 Jun; 22(6):631-40. PubMed ID: 25855554
[TBL] [Abstract][Full Text] [Related]
14. The effect of a killed porcine reproductive and respiratory syndrome virus (PRRSV) vaccine treatment on virus shedding in previously PRRSV infected pigs.
Nilubol D; Platt KB; Halbur PG; Torremorell M; Harris DL
Vet Microbiol; 2004 Aug; 102(1-2):11-8. PubMed ID: 15288922
[TBL] [Abstract][Full Text] [Related]
15. Immune responses of swine following DNA immunization with plasmids encoding porcine reproductive and respiratory syndrome virus ORFs 5 and 7, and porcine IL-2 and IFNgamma.
Xue Q; Zhao YG; Zhou YJ; Qiu HJ; Wang YF; Wu DL; Tian ZJ; Tong GZ
Vet Immunol Immunopathol; 2004 Dec; 102(3):291-8. PubMed ID: 15507312
[TBL] [Abstract][Full Text] [Related]
16. Protective immunity induced by a recombinant pseudorabies virus expressing the GP5 of porcine reproductive and respiratory syndrome virus in piglets.
Qiu HJ; Tian ZJ; Tong GZ; Zhou YJ; Ni JQ; Luo YZ; Cai XH
Vet Immunol Immunopathol; 2005 Jul; 106(3-4):309-19. PubMed ID: 15963827
[TBL] [Abstract][Full Text] [Related]
17. Immune responses in piglets infected with highly pathogenic porcine reproductive and respiratory syndrome virus.
Wang G; Song T; Yu Y; Liu Y; Shi W; Wang S; Rong F; Dong J; Liu H; Cai X; Zhou EM
Vet Immunol Immunopathol; 2011 Aug; 142(3-4):170-8. PubMed ID: 21612828
[TBL] [Abstract][Full Text] [Related]
18. Impact of a modified-live porcine reproductive and respiratory syndrome virus vaccine intervention on a population of pigs infected with a heterologous isolate.
Cano JP; Dee SA; Murtaugh MP; Pijoan C
Vaccine; 2007 May; 25(22):4382-91. PubMed ID: 17451850
[TBL] [Abstract][Full Text] [Related]
19. CD40 ligand expressed in adenovirus can improve the immunogenicity of the GP3 and GP5 of porcine reproductive and respiratory syndrome virus in swine.
Cao J; Wang X; Du Y; Li Y; Wang X; Jiang P
Vaccine; 2010 Nov; 28(47):7514-22. PubMed ID: 20851084
[TBL] [Abstract][Full Text] [Related]
20. Effects of two commercial European modified-live vaccines against porcine reproductive and respiratory syndrome viruses in pregnant gilts.
Scortti M; Prieto C; Martínez-Lobo FJ; Simarro I; Castro JM
Vet J; 2006 Nov; 172(3):506-14. PubMed ID: 16169756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
